ST

Strand Therapeutics

Boston, United States · Founded 2017

Headquarters
Boston
Employees
51–200
Founded
2017
Business Model
B2B

About

Strand Therapeutics is a clinical-stage, Boston-based biotechnology company leading the genetic medicine revolution, founded in 2017 by MIT biological engineers Jake Becraft and Tasuku Kitada, who created the first mRNA programming language. The company has taken complex, programmable mRNA medicines from design through manufacturing to patients, building a pipeline of next-generation therapeutics for cancers and autoimmune disease. Strand's interdisciplinary team is now developing new delivery systems for tissues across the body so genetic medicines can reach more patients.

Summary

Strand Therapeutics is a Biotech company based in Boston, United States, founded in 2017.

Similar Companies